Who owns the HERON THERAPEUTICS trademark?

The HERON THERAPEUTICS trademark is owned by Heron Therapeutics, Inc..

What class is the HERON THERAPEUTICS trademark registered in?

The HERON THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for HERON THERAPEUTICS?

The USPTO serial number for HERON THERAPEUTICS is 90260219.

What is the registration number for HERON THERAPEUTICS?

HERON THERAPEUTICS is registered under USPTO registration number 6660895.

Sealvo

Home Search: HERON THERAPEUTICSHERON THERAPEUTICS #90260219

Back

Updated Sep 27, 2026·9 searches this week

View on USPTO TSDR Find similar marks

HER

USPTO Trademark Record

REGISTERED

HERON THERAPEUTICS

SN 90260219·Reg 6660895·Filed Oct 16, 2020

Owner Heron Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

HERON THERAPEUTICS (Serial No. 90260219), Registration No. 6660895, is a registered US trademark filed on Oct 16, 2020 by Heron Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 01, 2028

Conflict Analysis

Full conflict analysis for HERON THERAPEUTICS (SN 90260219) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

HERON THERAPEUTICS (Reg. #6660895) is a registered US trademark that has been protecting its owner, Heron Therapeutics, Inc., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 16, 2020

SERIAL

90260219

REG#

6660895

REGISTERED

Mar 01, 2022

Filing Information

StatusREGISTERED

Filing DateOct 16, 2020

Serial Number90260219

Registration No.6660895

Registration DateMar 01, 2022

Status DateMar 01, 2022

Published for OppositionApr 27, 2021

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1573986

480Nov 09, 2020

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 30, 2014

First use in commerce: Jun 30, 2014

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

20 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Aug 16, 2023

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED-PRINCIPAL REGISTER

Mar 01, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 22, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 21, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Dec 18, 2021

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 17, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Nov 22, 2021

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 22, 2021

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 22, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 27, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Apr 27, 2021

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 07, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 23, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 23, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 23, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 23, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 23, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 16, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 06, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 20, 2020

NEW APPLICATION ENTERED

Other Marks by Heron Therapeutics, Inc.

Additional USPTO filings from the same owner.

CIN

CINVANTI (APREPITANT) INJECTABLE EMULSION

87893278

Heron Therapeutics, Inc.

REGISTERED

HER

HERON COMMITMENT PROGRAM

87667703

Heron Therapeutics, Inc.

REGISTERED

CIN

CINVANTI

87101607

Heron Therapeutics, Inc.

REGISTERED

APO

APONVIE

97617077

Heron Therapeutics, Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

HER

HERON THERAPEUTICS

90260225

Heron Therapeutics, Inc.

REGISTERED

HER

HERON

90401579

Heron Technologies LLC

REGISTERED

BLU

BLUE HERON

99517292

Blue Heron Companies, L.L.C.

REGISTERED

HER

HERON POINT

76138814

INTEGRACE, INC.

REGISTERED

Other Marks by Beth M. Goldman

Additional USPTO filings handled by the same attorney of record.

SAL

SALESFORCE TOWER

86420021

REGISTERED

CAR

CARROT ADS

97422250

REGISTERED

CIN

CINVANTI (APREPITANT) INJECTABLE EMULSION

87893278

REGISTERED

SMA

SMART BUSINESS NETWORK

78559532

REGISTERED

HERON THERAPEUTICS

Run a conflict check

Other Marks by Heron Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Beth M. Goldman

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company